Chargement en cours...
Abnl(17p) in AML: who will guard the guardian?
In this issue of Blood, Middeke and colleagues highlight the poor outcome of the abnormal (17p) [abnl(17p)] subgroup of cytogenetically adverse-risk acute myeloid leukemia (AML) even after allogeneic hematopoietic stem cell transplantation (HSCT).(1)
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014835/ https://ncbi.nlm.nih.gov/pubmed/24810623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-04-565515 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|